Literature DB >> 17684764

Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.

Marco Volante1, Luisella Righi, Sofia Asioli, Gianni Bussolati, Mauro Papotti.   

Abstract

Within the spectrum of neuroendocrine tumors arising in different organs, intermediate and controversial entities exist displaying a coexistence of neuroendocrine and nonneuroendocrine cell populations, and that are grouped under terms such as "goblet cell carcinoid", "mixed endocrine-exocrine carcinoma", "combined carcinomas", or "adenocarcinoma with neuroendocrine differentiation". These tumors may display variable amounts of the two components, potentially ranging from 1 to 99%, and variable structural patterns, ranging from single scattered neuroendocrine cells to a well-defined neuroendocrine tumor cell component organized in typical organoid, trabecular, or solid growth patterns. Although variably included in the site-specific World Health Organization classification schemes, clear definitions and diagnostic features are still missing, as well as a definite knowledge of their biological properties and histogenesis. In the present report, the main characteristics of tumors showing mixed neuroendocrine and nonneuroendocrine features will be described, using morphological patterns and site of origin as schematic guidelines. Moreover, molecular and clinical aspects, which might help to understand their possible histogenesis and biological behavior, will be reviewed.

Entities:  

Mesh:

Year:  2007        PMID: 17684764     DOI: 10.1007/s00428-007-0447-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  71 in total

1.  Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.

Authors:  K Hamilton; A Chiappori; S Olson; J Sawyers; D Johnson; K Washington
Journal:  Mod Pathol       Date:  2000-05       Impact factor: 7.842

Review 2.  Mixed exocrine-endocrine tumors of the pancreas.

Authors:  G Klöppel
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

3.  Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.

Authors:  Seung-Mo Hong; Mi-Jung Kim; David Y Pi; Daniel Jo; Eunsil Yu; Jae Y Ro
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

4.  Neuroendocrine differentiation is a common feature of thymic carcinoma.

Authors:  L Lauriola; R A Erlandson; J Rosai
Journal:  Am J Surg Pathol       Date:  1998-09       Impact factor: 6.394

5.  Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.

Authors:  Marileda Indinnimeo; Claudia Cicchini; Lorenzo Memeo; Alessandro Stazi; Claudia Provenza; Francesca Ricci; Pietro Luigi Mingazzini
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

6.  Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation.

Authors:  A Ooi; H Hayashi; S Katsuda; I Nakanishi
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

7.  Chromogranin A gene expression in non-small cell lung carcinomas.

Authors:  G Abbona; M Papotti; L Viberti; L Macrĭ; A Stella; G Bussolati
Journal:  J Pathol       Date:  1998-10       Impact factor: 7.996

8.  Adenoma, adenocarcinoma and mixed carcinoid-adenocarcinoma arising in a small lesion of the colon.

Authors:  Yu-Fei Jiao; Shin-ichi Nakamura; Tomio Arai; Tamotsu Sugai; Noriuki Uesugi; Wataru Habano; Masamichi Suzuki; Hideki Tazawa; Yuji Goukon
Journal:  Pathol Int       Date:  2003-07       Impact factor: 2.534

9.  Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma.

Authors:  M Noel; M C Delehaye; N Segond; F Lasmoles; B Caillou; P Gardet; P Fragu; M S Moukhtar
Journal:  Thyroid       Date:  1991       Impact factor: 6.568

10.  Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.

Authors:  W Blumenfeld; D K Chandhoke; P Sagerman; G K Turi
Journal:  Arch Pathol Lab Med       Date:  1996-05       Impact factor: 5.534

View more
  10 in total

Review 1.  The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.

Authors:  Marco Volante; Luisella Righi; Alfredo Berruti; Guido Rindi; Mauro Papotti
Journal:  Virchows Arch       Date:  2011-02-23       Impact factor: 4.064

Review 2.  [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].

Authors:  S Reu; J Neumann; T Kirchner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 3.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

4.  Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.

Authors:  Tingting Zhang; Dan Su; Zhiyuan Mao; Xiaochuan Guo; Lijie Wang; Li Bai
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.

Authors:  Stefano La Rosa; Francesca Franzi; Silvia Marchet; Giovanna Finzi; Moira Clerici; Davide Vigetti; Anna Maria Chiaravalli; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2008-12-09       Impact factor: 4.064

6.  Composite carcinoma of the stomach associated with sarcoid-like granulomas.

Authors:  Zorica Stojsic; Dimitrije Brasanac; Miodrag Stojiljkovic; Darko Babic; Tomislav Randjelovic; Tatjana Terzic
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  Clinicopathologic significance of gastric adenocarcinoma with neuroendocrine features.

Authors:  Jang Jin Kim; June Young Kim; Hoon Hur; Yong Kwan Cho; Sang-Uk Han
Journal:  J Gastric Cancer       Date:  2011-12-29       Impact factor: 3.720

Review 8.  Gastric collision tumors: an insight into their origin and clinical significance.

Authors:  Adamantios Michalinos; Anastasia Constantinidou; Michael Kontos
Journal:  Gastroenterol Res Pract       Date:  2015-02-12       Impact factor: 2.260

9.  Mixed neuroendocrine-non-neuroendocrine neoplasms of ascending colon: A case report.

Authors:  Shoichiro Mukai; Yuzo Hirata; Sho Ishikawa; Azusa Kai; Akihiro Kohata; Sho Okimoto; Seiji Fujisaki; Saburo Fukuda; Mamoru Takahashi; Toshikatsu Fukuda; Toshihiro Nishida; Hiroyuki Egi; Hideki Ohdan
Journal:  Int J Surg Case Rep       Date:  2020-09-23

10.  Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.

Authors:  Melissa Frizziero; Xin Wang; Bipasha Chakrabarty; Alexa Childs; Tu V Luong; Thomas Walter; Mohid S Khan; Meleri Morgan; Adam Christian; Mona Elshafie; Tahir Shah; Annamaria Minicozzi; Wasat Mansoor; Tim Meyer; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.